As a reproduction professional/andrologist, I want to make data driven decisions right away to shorten patient pathway for better outcome.
Translating Scientific Advances into Fertility Improvements
As a medtech R&D organization, Microfluidlabs harnesses academic talent to create cutting-edge fertility and andrology solutions. We're actively seeking dynamic partnerships to scale our innovations, like in case of our portable digital microscope for animal reproduction, thereby transforming the landscape of reproductive health.
Check out our product portfolio
The Animal Reproduction Mobile CASA Application, brought to market in a venture-backed partnership with Ongo Vettech. This on-the-market application provides veterinary reproduction specialists and breeders with the tools to digitally assess semen quality with improved accuracy against subjective assessment, offering a cost-effective solution to save on HR expenditures and failed pregnancy cycles. Our CASA solutions follow a unique 'Nespresso' model – offering an affordable purchase of the mobile microscope, with a complimentary smartphone app that operates exclusively with our specialized disposable slides, ensuring quality and convenience. Our collaboration with Ongo Vettech demonstrates our commitment to scaling innovative solutions worldwide, showcasing our expertise in forging strong, strategic partnerships.
Discover how our Animal Reproduction Mobile CASA Application can revolutionize your practice. Download our comprehensive white paper to explore in-depth product-market fit analysis, health technology assessment, indicative pricing, and an NPV model for strategic decision-making.
In its regulatory phase, the Human Mobile CASA Application represents a low-risk investment in the human medtech sphere, ready for divestment or out-licensing. This innovative, patented solution, proven in animal applications, offers a pocket-sized, smartphone-compatible tool for andrology practices and IVF services. It provides a cost-effective alternative to traditional methods, ensuring higher accuracy and outcomes without the need for large equipment. Our CASA solutions follow a unique 'Nespresso' model – offering an affordable purchase of the mobile microscope, with a complimentary smartphone app that operates exclusively with our specialized disposable slides, ensuring quality and convenience.
Learn how the Human Mobile CASA Application enhances fertility diagnostics. Get your hands on our detailed white paper covering customer pain points, solution efficacy, health technology assessment, and value-based pricing insights.
Seeking partners for divestment or out-licensing, the Biomimetic Embryo Maturation Dish is a pioneering prototype in reproductive technology. It offers veterinary specialists and breeders a cutting-edge tool to boost IVF success rates, leveraging advanced biomimetic microfluidic flow and optimal medium infusion for superior embryo maturation.
Uncover the potential of our Biomimetic Embryo Maturation Dish in advancing IVF success rates. Download the white paper now for a comprehensive look at its market alignment, health technology assessment, pricing strategy, and financial valuation through NPV analysis.
Meet our executive board
Microfluidlabs's inception was guided by a vision to bring precision and nature-aligned solutions to fertility care. We focus on portable data-driven, biomimetic approaches to ensure every intervention is as effective as possible.
Dr. Tamas Babel's journey from clinical practice to a seasoned executive in management consulting and the pharmaceutical sector sets him apart as a founder of MFL. His roles at BCG, coupled with his leadership in the pharmaceutical and healthcare payer sectors, have equipped him with unparalleled insights into health technology assessment and medtech innovation.
From his beginnings as a food engineer to ascending the ranks of Unilever's manufacturing and supply chain division, Istvan Takacs's career trajectory has been marked by a series of strategic advancements. His expertise was further honed through leading high-stakes acquisition projects and holding C-level positions in global food industry companies. At MFL, Istvan's extensive experience in operational excellence and strategic leadership shapes the innovative pathways the company pursues in the medtech field.
Hans Buss stands as a testament to excellence in corporate finance at the C-level, having built an illustrious career in the global FMCG sector. Renowned for driving regional growth through strategic mergers and acquisitions, his acumen has been instrumental in elevating market-leading food industry companies. As a board member at MFL, Hans brings a wealth of financial expertise and strategic foresight, invaluable in steering the company towards groundbreaking achievements in the medtech landscape.
Join the Microfluidlabs Innovation Circle
Stay ahead in the field of fertility technology. Sign up for exclusive insights on our pioneering medtech solutions, breakthrough research, and strategic partnership opportunities.
Thank you for subscribing!
Have a great day!